Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-259
Closed -$20.9K 466
2023
Q1
$20.9K Hold
259
0.01% 699
2022
Q4
$19.4K Hold
259
0.01% 564
2022
Q3
$17K Hold
259
0.01% 608
2022
Q2
$18K Buy
259
+16
+7% +$1.19K 0.01% 571
2022
Q1
$19K Hold
243
0.01% 575
2021
Q4
$19K Hold
243
0.01% 584
2021
Q3
$18K Hold
243
0.01% 527
2021
Q2
$16K Buy
+243
New +$16.2K 0.01% 592

Other funds holding HOLX

Accel Wealth Management's HOLX Position: Q2 2023 in Review

Accel Wealth Management sold out of Hologic (HOLX) in Q2 2023, closing a stake of 259 shares — an estimated $20.9K sold.

Accel Wealth Management first reported a position in HOLX in Q2 2021 and held it in 8 quarters. The position peaked at $20.9K in Q1 2023. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Accel Wealth Management reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 259 Hologic shares in Q2 2023, an estimated $20.9K.
  • Accel Wealth Management first reported a position in Hologic in Q2 2021 and held it in 8 quarters.
  • Accel Wealth Management's Hologic position peaked at $20.9K in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.